309 related articles for article (PubMed ID: 17998470)
21. From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies.
Crotti L; Brugada P; Calkins H; Chevalier P; Conte G; Finocchiaro G; Postema PG; Probst V; Schwartz PJ; Behr ER
Europace; 2023 Aug; 25(8):. PubMed ID: 37622577
[TBL] [Abstract][Full Text] [Related]
22. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.
Tester DJ; Ackerman MJ
Circulation; 2011 Mar; 123(9):1021-37. PubMed ID: 21382904
[No Abstract] [Full Text] [Related]
23. [Sudden cardiac death in athletes with an apparently normal heart: the channelopathies].
Giustetto C; Gaita F
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):78S-82S. PubMed ID: 19195312
[TBL] [Abstract][Full Text] [Related]
24. EMQN: Recommendations for genetic testing in inherited cardiomyopathies and arrhythmias.
Hayesmoore JB; Bhuiyan ZA; Coviello DA; du Sart D; Edwards M; Iascone M; Morris-Rosendahl DJ; Sheils K; van Slegtenhorst M; Thomson KL
Eur J Hum Genet; 2023 Sep; 31(9):1003-1009. PubMed ID: 37443332
[TBL] [Abstract][Full Text] [Related]
25. Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.
Bermúdez-Jiménez FJ; Carriel V; Brodehl A; Alaminos M; Campos A; Schirmer I; Milting H; Abril BÁ; Álvarez M; López-Fernández S; García-Giustiniani D; Monserrat L; Tercedor L; Jiménez-Jáimez J
Circulation; 2018 Apr; 137(15):1595-1610. PubMed ID: 29212896
[TBL] [Abstract][Full Text] [Related]
26. [Cardiac sodium channelopathy from bench to bedside].
Zhang YM; Zhou N
Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568
[No Abstract] [Full Text] [Related]
27. Ion channel diseases in children: manifestations and management.
Schwartz PJ; Crotti L
Curr Opin Cardiol; 2008 May; 23(3):184-91. PubMed ID: 18382205
[TBL] [Abstract][Full Text] [Related]
28. Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I.
Spooner PM; Albert C; Benjamin EJ; Boineau R; Elston RC; George AL; Jouven X; Kuller LH; MacCluer JW; Marbán E; Muller JE; Schwartz PJ; Siscovick DS; Tracy RP; Zareba W; Zipes DP
Circulation; 2001 May; 103(19):2361-4. PubMed ID: 11352884
[TBL] [Abstract][Full Text] [Related]
29. Cardiac Channelopathies: Recognition, Treatment, Management.
Hickey KT; Elzomor A
AACN Adv Crit Care; 2018; 29(1):43-57. PubMed ID: 29496713
[TBL] [Abstract][Full Text] [Related]
30. Advising a cardiac disease gene positive yet phenotype negative or borderline abnormal athlete: is sporting disqualification really necessary?
Richard P; Denjoy I; Fressart V; Wilson MG; Carré F; Charron P
Br J Sports Med; 2012 Nov; 46 Suppl 1():i59-68. PubMed ID: 23097481
[TBL] [Abstract][Full Text] [Related]
31. Inherited Cardiac Arrhythmia Syndromes: Focus on Molecular Mechanisms Underlying TRPM4 Channelopathies.
Amarouch MY; El Hilaly J
Cardiovasc Ther; 2020; 2020():6615038. PubMed ID: 33381229
[TBL] [Abstract][Full Text] [Related]
32. Channelopathies, genetic testing and risk stratification.
Wilde AAM; Amin A
Int J Cardiol; 2017 Jun; 237():53-55. PubMed ID: 28343764
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Strategies Targeting Inherited Cardiomyopathies.
Varian K; Tang WHW
Curr Heart Fail Rep; 2017 Aug; 14(4):321-330. PubMed ID: 28660543
[TBL] [Abstract][Full Text] [Related]
34. Arrhythmogenic Cardiomyopathy.
Corrado D; Basso C; Judge DP
Circ Res; 2017 Sep; 121(7):784-802. PubMed ID: 28912183
[TBL] [Abstract][Full Text] [Related]
35. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Ackerman MJ; Priori SG; Willems S; Berul C; Brugada R; Calkins H; Camm AJ; Ellinor PT; Gollob M; Hamilton R; Hershberger RE; Judge DP; Le Marec H; McKenna WJ; Schulze-Bahr E; Semsarian C; Towbin JA; Watkins H; Wilde A; Wolpert C; Zipes DP
Heart Rhythm; 2011 Aug; 8(8):1308-39. PubMed ID: 21787999
[No Abstract] [Full Text] [Related]
36. Congenital short QT syndrome: landmarks of the newest arrhythmogenic cardiac channelopathy.
Pérez Riera AR; Paixão-Almeida A; Barbosa-Barros R; Yanowitz FG; Baranchuk A; Dubner S; Palandri Chagas AC
Cardiol J; 2013; 20(5):464-71. PubMed ID: 23677719
[TBL] [Abstract][Full Text] [Related]
37. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
[TBL] [Abstract][Full Text] [Related]
38. Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.
Marian AJ; Asatryan B; Wehrens XHT
Cardiovasc Res; 2020 Jul; 116(9):1600-1619. PubMed ID: 32348453
[TBL] [Abstract][Full Text] [Related]
39. A clinical approach to inherited arrhythmias.
Cerrone M; Cummings S; Alansari T; Priori SG
Circ Cardiovasc Genet; 2012 Oct; 5(5):581-90. PubMed ID: 23074337
[No Abstract] [Full Text] [Related]
40. [Genetic bases of arrhythmias].
Brugada R
Rev Esp Cardiol; 1998 Apr; 51(4):274-85. PubMed ID: 9608799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
